Trial intelligence / Profile preview

Valproate level variation across menstrual cycle phases in bipolar disorder

ChiCTR1900027184Phase 4Recruiting

Sponsor
Jingzhou Mental Health Center
Start
Nov 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of valproic acid in bipolar disorder (BD), sponsored by Jingzhou Mental Health Center. Primary endpoints: Valproate level and Blood progesterone level. Started Nov 2019; status: recruiting.

02

Drugs

valproic acid
03

Conditions

bipolar disorder (BD)

Beyond the preview

Go deeper on ChiCTR1900027184.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900027184.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call